Here are five recent statistics that illustrate the mounting supply chain pressures facing ASCs and other healthcare providers:
1. Medical supply chain costs are projected to increase 2.41% in 2026.
2. Supply costs accounted for 13% of hospitals’ expenses in 2024.
3. Healthcare analytics company Vizient predicted a 3.35% rise in pharmaceutical prices in 2026, driven by a surge in the use of high-cost therapies like GLP-1s and CAR-T treatments.
4. About 250 medications are already in shortage nationwide, and this number could get worse if tariffs are implemented by President Donald Trump.
5. A recent analysis from GlobalData found that about 70% of medical devices marketed in the U.S. are manufactured solely overseas.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
